GRI Bio
1 hedge funds and large institutions have $887K invested in GRI Bio in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
83% less capital invested
Capital invested by funds: $5.09M → $887K (-$4.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$1.7M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$3.82K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
Altium Capital Management
New York
| $808K | -$1.7M | -15 | -56% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $28.7K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $23K | – | – | – |
|
|
SWP
4
Stratos Wealth Partners
Beachwood,
Ohio
| $15.5K | – | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $11.5K | – | – | – |
|
6
Wells Fargo
San Francisco,
California
| $22 | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$3.82K | – | – |
|
GRI Hedge Fund Activity: Q3 2023 in Review
1 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in GRI Bio (GRI) for Q3 2023, worth a combined $887K — down 83% from $5.09M a quarter earlier.
Fund positioning in GRI was balanced in Q3 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Altium Capital Management, cutting an estimated $1.7M.
- 1 institutional investor held GRI Bio (GRI) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $887K of GRI Bio stock for Q3 2023, down 83% quarter-over-quarter.
- 0 funds opened new GRI Bio positions in Q3 2023 and 0 closed out.
- The largest GRI Bio seller in Q3 2023 was Altium Capital Management, an estimated $1.7M sold.
Based on aggregated 13F filings for Q3 2023.